Further work is required to investigate the functional role of Rab35 in ovarian cancer, but this gene may have use as a biomarker of AR function in ovarian cancer, thus being able to predict those patients who are likely to respond to antiandrogen therapy. This evidence concerns the gene RAB35 and ovarian carcinoma.